Sign In
Buy MYO
$1.00
+0.0699 (+7.52%)
At Close: Jul 30, 2026
Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates
07:56pm, Wednesday, 05'th May 2021
Myomo, Inc. (MYO) delivered earnings and revenue surprises of 17.39% and 31.24%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Myomo Participates in Ground-breaking Brain-computer Interface Trial
08:05am, Thursday, 01'st Apr 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, A High Risk And High Potential Investment At The Right Time
02:26pm, Wednesday, 24'th Mar 2021
Myomo develops, manufactures, and sells a wearable medical device for stroke patients that lost control or strength in their arms. Myomo's recent quarter and future growth prospects look bright in par
Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2020 Results - Earnings Call Transcript
08:47pm, Wednesday, 10'th Mar 2021
Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2020 Results - Earnings Call Transcript
Myomo to Participate in Three Investment Conferences During the Month of March
04:20pm, Thursday, 04'th Mar 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
04:15pm, Thursday, 04'th Mar 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Germany's Largest Statutory Health Insurance Company Approves MyoPro
08:30am, Tuesday, 16'th Feb 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo to Present at the Winter Wonderland – Best Ideas from the Buy-side Conference
04:05pm, Friday, 12'th Feb 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from
Myomo® Forms Joint Venture to Manufacture and Sell the Company's Products in China
06:30am, Tuesday, 26'th Jan 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from
Myomo to Present at Sidoti & Company Virtual Microcap Conference
09:03am, Wednesday, 18'th Nov 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from
Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q3 2020 Results - Earnings Call Transcript
09:29pm, Tuesday, 10'th Nov 2020
Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q3 2020 Results - Earnings Call Transcript
Myomo to Report Third Quarter Financial Results on November 10, 2020
08:30am, Tuesday, 03'rd Nov 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from
AMD Vs. Nvidia: The Winner And Still Champion Is Nvidia (NASDAQ:AMD)
06:16pm, Monday, 19'th Oct 2020
Nvidia's financial metrics are superior even before the ARM deal. Nvidia's margins are vastly better than AMD's.
Artificial Intelligence (AI) Market Insights on Fortified Dairy Products Market and Forecast Assumptions
11:36am, Wednesday, 30'th Sep 2020
Sep 30, 2020 (AmericaNewsHour) --
Global Artificial Intelligence (AI) Market valued approximately USD 16 billion in 2016 is anticipated to grow with a...
